Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065803
Filing Date
2015-11-16
Accepted
2015-11-16 14:19:04
Documents
18
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423466_10q.htm 10-Q 447704
2 EXHIBIT 10.1 v423466_ex10-1.htm EX-10.1 479148
3 EXHIBIT 31.1 v423466_ex31-1.htm EX-31.1 7984
4 EXHIBIT 32.1 v423466_ex32-1.htm EX-32.1 4368
5 GRAPHIC image_001.jpg GRAPHIC 3469
6 GRAPHIC image_008.jpg GRAPHIC 1488
7 GRAPHIC image_009.jpg GRAPHIC 1710
8 GRAPHIC image_004.jpg GRAPHIC 9073
9 GRAPHIC image_005.jpg GRAPHIC 1764
10 GRAPHIC image_006.jpg GRAPHIC 5668
11 GRAPHIC image_007.jpg GRAPHIC 3474
12 GRAPHIC image_010.jpg GRAPHIC 114225
  Complete submission text file 0001144204-15-065803.txt   4911454

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT arni-20150930.xml EX-101.INS 1107010
14 XBRL TAXONOMY EXTENSION SCHEMA arni-20150930.xsd EX-101.SCH 48379
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20150930_cal.xml EX-101.CAL 20650
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20150930_def.xml EX-101.DEF 234364
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20150930_lab.xml EX-101.LAB 322614
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20150930_pre.xml EX-101.PRE 264250
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52153 | Film No.: 151233444
SIC: 2834 Pharmaceutical Preparations